MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
89bio, Inc. (Nasdaq: ETNB)
Attachments
89bio
Parents
Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Companies: Acquired_(M&A)
Finance & Acquisitions: Roche
Industry: San Francisco, California
Children
Finance & Acquisitions: 89bio
Founded 2018
Key People: 89bio
Organization & Developments: 89bio
San Francisco, California
Jumps
CymaBay Therapeutics, Inc. (NASDAQ: CBAY)
Enanta Pharmaceuticals, Inc (NASDAQ: ENTA)*
ENYO Pharma SA
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)
Metacrine, Inc. (NASDAQ: MTCR)
Terns Pharmaceuticals, Inc. (NASDAQ: TERN)*